{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:14:51Z","timestamp":1781658891441,"version":"3.54.5"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,3,1]]},"DOI":"10.1093\/jac\/dkl006","type":"journal-article","created":{"date-parts":[[2006,1,28]],"date-time":"2006-01-28T01:33:17Z","timestamp":1138411997000},"page":"511-519","source":"Crossref","is-referenced-by-count":48,"title":["Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: impact on the outcome"],"prefix":"10.1093","volume":"57","author":[{"given":"Chi-Tai","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Yi","family":"Shau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jann-Tay","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Ching","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loreen Y. L.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Chwen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,1,27]]},"reference":[{"key":"key\n\t\t\t\t20171010140507_B1","doi-asserted-by":"crossref","unstructured":"Boyce JM, Cookson B, Christiansen K et al. Methicillin-resistant Staphylococcus aureus. Lancet Infect Dis2005; 5: 653\u201363.","DOI":"10.1016\/S1473-3099(05)70243-7"},{"key":"key\n\t\t\t\t20171010140507_B2","doi-asserted-by":"crossref","unstructured":"Duckworth G. Controlling methicillin resistant Staphylococcus aureus: time to return to more stringent methods of control in the United Kingdom? BMJ2003; 327: 1177\u20138.","DOI":"10.1136\/bmj.327.7425.1177"},{"key":"key\n\t\t\t\t20171010140507_B3","unstructured":"NINSS report on surgical site infection and hospital-acquired bacteremia. Commun Dis Rep CDR Wkly2000; 10: 213\u20136."},{"key":"key\n\t\t\t\t20171010140507_B4","doi-asserted-by":"crossref","unstructured":"Pittet D, Wenzel RP. Nosocomial bloodstream infections: secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med1995; 155: 1177\u201384.","DOI":"10.1001\/archinte.1995.00430110089009"},{"key":"key\n\t\t\t\t20171010140507_B5","doi-asserted-by":"crossref","unstructured":"Edmond MB, Wallace SE, McClish DK et al. Nosocomial bloodstream infections in United States hospitals: a 3-year analysis. Clin Infect Dis1999; 29: 239\u201344.","DOI":"10.1086\/520192"},{"key":"key\n\t\t\t\t20171010140507_B6","unstructured":"Chen ML, Chang SC, Pan HJ et al. Longitudinal analysis of methicillin-resistant Staphylococcus aureus isolates at a teaching hospital in Taiwan. J Formos Med Assoc1999; 98: 426\u201332."},{"key":"key\n\t\t\t\t20171010140507_B7","doi-asserted-by":"crossref","unstructured":"Hsueh PR, Teng LJ, Chen WH et al. Increasing prevalence of methicillin-resistant Staphylococcus aureus causing nosocomial infections at a university hospital in Taiwan from 1986 to 2001. Antimicrob Agents Chemother2004; 48: 1361\u20134.","DOI":"10.1128\/AAC.48.4.1361-1364.2004"},{"key":"key\n\t\t\t\t20171010140507_B8","doi-asserted-by":"crossref","unstructured":"Cosgrove SE, Sakoulas G, Perencevich EN et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis2003; 36: 53\u20139.","DOI":"10.1086\/345476"},{"key":"key\n\t\t\t\t20171010140507_B9","doi-asserted-by":"crossref","unstructured":"Blot SI, Vandewoude KH, Hoste EA et al. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med2002; 162: 2229\u201335.","DOI":"10.1001\/archinte.162.19.2229"},{"key":"key\n\t\t\t\t20171010140507_B10","doi-asserted-by":"crossref","unstructured":"Harbarth S, Rutschmann O, Sudre P et al. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med1998; 158: 182\u20139.","DOI":"10.1001\/archinte.158.2.182"},{"key":"key\n\t\t\t\t20171010140507_B11","doi-asserted-by":"crossref","unstructured":"Romero-Vivas J, Rubio M, Fernandez C et al. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis1995; 21: 1417\u201323.","DOI":"10.1093\/clinids\/21.6.1417"},{"key":"key\n\t\t\t\t20171010140507_B12","unstructured":"Centers for Disease Control and Prevention. Preventing the spread of vancomycin resistance, recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR1995; 44 (RR12): 1\u201313."},{"key":"key\n\t\t\t\t20171010140507_B13","doi-asserted-by":"crossref","unstructured":"Amyes SGB. Treatment of staphylococcal infection: prescriptions must be part of a package that includes infection control. BMJ2005; 330: 976\u20137.","DOI":"10.1136\/bmj.330.7498.976"},{"key":"key\n\t\t\t\t20171010140507_B14","doi-asserted-by":"crossref","unstructured":"Roghmann MC. Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia. Arch Intern Med2000; 160: 1001\u20134.","DOI":"10.1001\/archinte.160.7.1001"},{"key":"key\n\t\t\t\t20171010140507_B15","doi-asserted-by":"crossref","unstructured":"Lodise TP, McKinnon PS, Swiderski L et al. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis2003; 36: 1418\u201323.","DOI":"10.1086\/375057"},{"key":"key\n\t\t\t\t20171010140507_B16","doi-asserted-by":"crossref","unstructured":"Kim SH, Park WB, Lee KD et al. Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother2004; 54: 489\u201397.","DOI":"10.1093\/jac\/dkh366"},{"key":"key\n\t\t\t\t20171010140507_B17","doi-asserted-by":"crossref","unstructured":"Cordova SP, Heath CH, McGechie DB et al. Methicillin-resistant Staphylococcus aureus bacteraemia in Western Australian teaching hospitals, 1997\u20131999: risk factors, outcomes and implications for management. J Hosp Infect2004; 56: 22\u20138.","DOI":"10.1016\/j.jhin.2003.10.009"},{"key":"key\n\t\t\t\t20171010140507_B18","doi-asserted-by":"crossref","unstructured":"Coello R, Glynn JR, Gaspar C et al. Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA. J Hosp Infect1997; 37: 39\u201346.","DOI":"10.1016\/S0195-6701(97)90071-2"},{"key":"key\n\t\t\t\t20171010140507_B19","doi-asserted-by":"crossref","unstructured":"Leibovici L, Samra Z, Konigsberger H et al. Long-term survival following bacteremia or fungemia. JAMA1995; 274: 807\u201312.","DOI":"10.1001\/jama.274.10.807"},{"key":"key\n\t\t\t\t20171010140507_B20","unstructured":"Kloos WE, Bannerman TL. Staphylococcus and Micrococcus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology. 7th edn. Washington, D.C.: ASM Press, 1999; 264\u201382."},{"key":"key\n\t\t\t\t20171010140507_B21","unstructured":"National Committee for Clinical Laboratory Standard. Performance Standards for Antimicrobial Disk Susceptibility Tests-4th edition: Approved Standard M2-A6. NCCLS, Villanova, PA, USA, 1990."},{"key":"key\n\t\t\t\t20171010140507_B22","doi-asserted-by":"crossref","unstructured":"Tenover FC, Lancaster MV, Hill BC, et al. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol1998; 36: 1020\u20137.","DOI":"10.1128\/JCM.36.4.1020-1027.1998"},{"key":"key\n\t\t\t\t20171010140507_B23","unstructured":"Hsieh GY, Chen PC, Wang JD. Verification and correction of error for death registration data of the Department of Health R.O.C. between 1980 and 1997. Taiwan J Public Health2002; 21: 329\u201338."},{"key":"key\n\t\t\t\t20171010140507_B24","doi-asserted-by":"crossref","unstructured":"Knaus WA, Draper EA, Wagner DP et al. APACHE II: A severity of disease classification system. Crit Care Med1985; 13: 818\u201329.","DOI":"10.1097\/00003246-198510000-00009"},{"key":"key\n\t\t\t\t20171010140507_B25","doi-asserted-by":"crossref","unstructured":"American College of Chest Physicians\/Society of Critical Care Medicine Consensus Conference Committee: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med1992; 20: 864\u2013910.","DOI":"10.1097\/00003246-199206000-00025"},{"key":"key\n\t\t\t\t20171010140507_B26","doi-asserted-by":"crossref","unstructured":"McCabe WR, Jackson GG. Gram-negative bacteremia. Arch Inter Med1962; 110: 847\u201364.","DOI":"10.1001\/archinte.1962.03620240029006"},{"key":"key\n\t\t\t\t20171010140507_B27","doi-asserted-by":"crossref","unstructured":"Lodise TP Jr, McKinnon PS, Rybak M. Prediction model to identify patients with Staphylococcus aureus bacteremia at risk for methicillin resistance. Infect Control Hosp Epidemiol2003; 24: 655\u201361.","DOI":"10.1086\/502269"},{"key":"key\n\t\t\t\t20171010140507_B28","doi-asserted-by":"crossref","unstructured":"Vardakas KZ, Samonis G, Chrysanthopoulou SA et al. Role of glycopeptides as part of initial empirical treatment of febrile neutropenic patients: a meta-analysis of randomised controlled trials. Lancet Infect Dis2005; 5: 431\u20139.","DOI":"10.1016\/S1473-3099(05)70164-X"},{"key":"key\n\t\t\t\t20171010140507_B29","doi-asserted-by":"crossref","unstructured":"Lowy FD. Staphylococcus aureus infections. N Engl J Med1998; 339: 520\u201332.","DOI":"10.1056\/NEJM199808203390806"},{"key":"key\n\t\t\t\t20171010140507_B30","doi-asserted-by":"crossref","unstructured":"Gonzalez C, Rubio M, Romero-Vivas J et al. Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis1999; 29: 1171\u20137.","DOI":"10.1086\/313440"},{"key":"key\n\t\t\t\t20171010140507_B31","doi-asserted-by":"crossref","unstructured":"Levine DP, Fromm BS, Reddy BR. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med1991; 115: 674\u201380.","DOI":"10.7326\/0003-4819-115-9-674"},{"key":"key\n\t\t\t\t20171010140507_B32","doi-asserted-by":"crossref","unstructured":"Small PM, Chambers HF. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug abusers. Antimicrob Agents Chemother1990; 34: 1227\u201331.","DOI":"10.1128\/AAC.34.6.1227"},{"key":"key\n\t\t\t\t20171010140507_B33","doi-asserted-by":"crossref","unstructured":"Sakoulas G, Moise-Broder PA, Schentag J et al. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol2004; 42: 2398\u2013402.","DOI":"10.1128\/JCM.42.6.2398-2402.2004"},{"key":"key\n\t\t\t\t20171010140507_B34","doi-asserted-by":"crossref","unstructured":"Chang SC, Fang CT, Chen CY et al. In vitro activity of quinupristin\/dalfopristin against common pathogenic bacteria isolated in Taiwan. Diagn Microbiol Infect Dis1999; 33: 299\u2013303.","DOI":"10.1016\/S0732-8893(98)00147-3"},{"key":"key\n\t\t\t\t20171010140507_B35","doi-asserted-by":"crossref","unstructured":"Fang CT, Chang SC, Chen YC et al. In vitro activity of linezolid against clinical gram-positive bacterial isolates from Taiwan: an area with a high prevalence of antibiotic resistance. Int J Antimicrob Agents2001; 18: 267\u201370.","DOI":"10.1016\/S0924-8579(01)00384-3"},{"key":"key\n\t\t\t\t20171010140507_B36","doi-asserted-by":"crossref","unstructured":"Cruciani M, Gatti G, Lazzarini L et al. Penetration of vancomycin into human lung tissue. J Antimicrob Chemother1996; 38: 865\u20139.","DOI":"10.1093\/jac\/38.5.865"},{"key":"key\n\t\t\t\t20171010140507_B37","doi-asserted-by":"crossref","unstructured":"Soto J, Sacristan JA, Alsar MJ. Necessity of a loading dose when using vancomycin in critically ill patients. J Antimicrob Chemother1991; 27: 875.","DOI":"10.1093\/jac\/27.6.875"},{"key":"key\n\t\t\t\t20171010140507_B38","doi-asserted-by":"crossref","unstructured":"Huletsky A, Giroux R, Rossbach V et al. New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci. J Clin Microbiol2004; 42: 1875\u201384.","DOI":"10.1128\/JCM.42.5.1875-1884.2004"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/57\/3\/511\/2203784\/dkl006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T11:10:10Z","timestamp":1586689810000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/57\/3\/511\/738104\/Early-empirical-glycopeptide-therapy-for-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,27]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2006,1,27]]},"published-print":{"date-parts":[[2006,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkl006","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,3]]},"published":{"date-parts":[[2006,1,27]]}}}